2026-01-22 - Analysis Report
**Company Overview**
Invesco is a financial services company that offers a range of investment products and services.

**Return Rate Comparison**
| | Cumulative Return | Divergence |
| --- | --- | --- |
| Review Stock (IVZ) | 31.37% | N/A |
| Comparison Stock (VOO) | 91.55% | -60.70 |

The review stock has a lower cumulative return compared to the comparison stock, indicating a lower rate of return.

**Alpha, Beta Analysis**

| Period | CAGR | MDD | Alpha | Beta | Market Cap |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -43.0% | 39.3% | -48.0% | 1.4 | 7.5B |
| 2017-2019 | -26.0% | 39.3% | -43.0% | 1.2 | 8.0B |
| 2018-2020 | -26.0% | 37.6% | -47.0% | 1.5 | 7.8B |
| 2019-2021 | 29.0% | 32.4% | -14.0% | 1.6 | 10.3B |
| 2020-2022 | 20.0% | 32.4% | 22.0% | 1.6 | 8.0B |
| 2021-2023 | -3.0% | 31.1% | -4.0% | 1.5 | 8.0B |
| 2022-2024 | -4.0% | 26.6% | -23.0% | 1.4 | 7.8B |
| 2023-2025 | 32.0% | 34.3% | -30.0% | 1.5 | 11.7B |

The Alpha values indicate the review stock has consistently underperformed the market, with a median Alpha value of -42.00%. The Beta values indicate moderate volatility, with a median Beta value of 1.4.

**Recent Stock Price Fluctuations**

| | Close | 5-day SMA | 20-day SMA | 60-day SMA |
| --- | --- | --- | --- | --- |
| Review Stock | $29.17 | $28.83 | $27.86 | $25.60 |

The review stock has experienced a sharp rebound, with a 4.51% increase in price over the last trading day. The 5-day SMA, 20-day SMA, and 60-day SMA indicate a downward trend.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

| Indicator | Value |
| --- | --- |
| RSI | 66.35 |
| PPO | -0.04 |
| Hybrid Signal | Buy (Cash 0%) |
| Risk Level | Medium |
| Recent Relative Divergence Change | 4.40 (+) |
| 7-day Rank Change | 0 (0) |
| 7-day Dynamic Expected Return Change | 0.00 (0) |

The RSI value indicates the review stock is overbought. The PPO value suggests a bearish trend. The hybrid signal indicates a buy signal with a risk level of medium.

**Expected Return**
-111.10%

The expected return is significantly negative, indicating a high risk of loss if invested long-term.

**Recent News & Significant Events**

These recent news articles indicate a positive sentiment:

* Invesco (IVZ) Stock Trades Up, Here Is Why - The Globe and Mail
* Invesco ETF Comparisons Put Spotlight On RSP QQQ And Valuation - simplywall.st
* IVZ Stock Upgraded to "Outperform" with Raised Price Target by R - GuruFocus
* Invesco (NYSE:IVZ) Sets New 52-Week High After Analyst Upgrade - MarketBeat
* Invesco stock rating upgraded by RBC Capital on improved growth outlook - Investing.com Nigeria
* Why Invesco (IVZ) Stock Is Trading Up Today - Finviz

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.42 (~Buy)
- Opinions: 11
- Target Price (avg/high/low): 29.39 / 33.50 / 24.00

Analysts have a buy consensus with a moderate target price range.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-11-04 | 0.67 | 1.64 B$ |
| 2025-08-01 | -0.03 | 1.52 B$ |
| 2025-04-28 | 0.38 | 1.53 B$ |
| 2024-10-29 | 0.12 | 1.52 B$ |
| 2025-11-04 | 0.12 | 1.52 B$ |

The review stock has experienced a positive earnings per share (EPS) in the last quarter, but a negative EPS in one of the previous quarters. Revenue has fluctuated, with a peak in the last quarter.

**Financial Information: Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | 1.64B | 34.17% |
| 2025-06-30 | 1.52B | 33.28% |
| 2025-03-31 | 1.53B | 36.33% |
| 2024-12-31 | 1.59B | 37.83% |
| 2024-09-30 | 1.52B | 25.76% |

Revenue has fluctuated, with a peak in the last three quarters. Profit margin has improved in the last quarter.

**Financial Information: Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | 14.01B | 2.47% |
| 2025-06-30 | 13.87B | 1.47% |
| 2025-03-31 | 14.70B | 1.57% |
| 2024-12-31 | 14.56B | 1.84% |
| 2024-09-30 | 14.75B | 0.77% |

Equity has fluctuated, with a peak in the last quarter. Return on equity (ROE) has improved in the last quarter.

**Comprehensive Analysis**
The review stock has a lower cumulative return compared to the comparison stock. The Alpha values indicate the review stock has consistently underperformed the market. The recent stock price fluctuations indicate a sharp rebound. The RSI value indicates the review stock is overbought. Analysts have a buy consensus with a moderate target price range. The earnings per share have fluctuated, and revenue has improved in the last quarter.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.